Intervention
Selumetinib Sulfate
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNCT05564377 · 2023-04-07
RECRUITINGTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)NCT03155620 · 2017-07-31
ACTIVE_NOT_RECRUITINGCommon conditions
Advanced Malignant Solid Neoplasm2Recurrent Malignant Solid Neoplasm2Anatomic Stage III Breast Cancer AJCC v81Anatomic Stage IV Breast Cancer AJCC v81Ann Arbor Stage III Non-Hodgkin Lymphoma1Ann Arbor Stage IV Non-Hodgkin Lymphoma1Histiocytic Sarcoma1Juvenile Xanthogranuloma1Langerhans Cell Histiocytosis1Locally Advanced Malignant Solid Neoplasm1Malignant Female Reproductive System Neoplasm1Malignant Glioma1Metastatic HER2-Negative Breast Carcinoma1Metastatic Malignant Solid Neoplasm1Recurrent Childhood Rhabdomyosarcoma1Recurrent Endometrial Carcinoma1Recurrent Ependymoma1Recurrent Ewing Sarcoma1Recurrent Fallopian Tube Carcinoma1Recurrent Glioma1Recurrent Hepatoblastoma1Recurrent Langerhans Cell Histiocytosis1Recurrent Malignant Female Reproductive System Neoplasm1Recurrent Malignant Germ Cell Tumor1Recurrent Medulloblastoma1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING1
RECRUITING1
Phase mix
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.